Hahahhaha yeah, what ever surprises there are, it has gone against the share price, Go Figure!!!While there is fear of a takever, why list the shares to the public?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%